Log in
Registersteady-state in patients [Design Issues]
posted by Helmut 
– Vienna, Austria, 2024-12-17 10:45 (29 d 02:13 ago) – Posting: # 24319
Views: 1,561
Hi Christian,
of course, multiple dose studies are recommended in patients where the treatment cannot be interrupted.
However, Libaiyi asked in his post about steady-state as a means to reduce variability. That is not acceptable.
of course, multiple dose studies are recommended in patients where the treatment cannot be interrupted.
However, Libaiyi asked in his post about steady-state as a means to reduce variability. That is not acceptable.
—
Dif-tor heh smusma 🖖🏼 Довге життя Україна!![[image]](https://static.bebac.at/pics/Blue_and_yellow_ribbon_UA.png)
Helmut Schütz
![[image]](https://static.bebac.at/img/CC by.png)
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Dif-tor heh smusma 🖖🏼 Довге життя Україна!
Helmut Schütz
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Complete thread:
- Do regulatory agencies accept steady-state equivalence studies? libaiyi 2024-12-04 08:34 [Design Issues]
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- HVD(P)s: steady state = history Helmut 2024-12-04 09:37
- HVD(P)s: steady state = history libaiyi 2024-12-04 09:52
- HVD(P)s: steady state = history dshah 2024-12-05 07:22
- HVD(P)s: steady state = history libaiyi 2024-12-04 09:52
- Do regulatory agencies accept steady-state equivalence studies? xtianbadillo 2024-12-16 20:59
- steady-state in patientsHelmut 2024-12-17 09:45
- steady-state in patients qualityassurance 2025-01-09 10:59
- steady-state in patientsHelmut 2024-12-17 09:45
- HVD(P)s: steady state = history Helmut 2024-12-04 09:37
Ing. Helmut Schütz